Cargando…
Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
Lymphoid malignancies, mainly including lymphocytic leukemia and lymphoma, are a group of heterogeneous diseases. Although the clinical outcome of patients has been significantly improved with current immuno-chemotherapy, definitive biomarkers remain to be investigated, particularly those reflecting...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101819/ https://www.ncbi.nlm.nih.gov/pubmed/24252620 http://dx.doi.org/10.1186/2050-7771-1-24 |